These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1790443)

  • 1. Drug-related lupus.
    Hess EV; Mongey AB
    Bull Rheum Dis; 1991; 40(4):1-8. PubMed ID: 1790443
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
    Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
    Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procainamide and lupus erythematosus.
    Sokol SA
    J Maine Med Assoc; 1973 Mar; 64(3):54-5 passim. PubMed ID: 4540169
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary C1q deficiency and systemic lupus erythematosus.
    Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
    QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical manifestations of lupus erythematosus disseminatus from the rheumatologist's standpoint].
    Kahn MF; de Seze M
    Rhumatologie; 1970 Feb; 22(2):65-75. PubMed ID: 5505283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lupus erythematosus. 2. Systemic Lupus erythematosus: antibody symptomatology, other laboratory evidence, diagnosis, course and prognosis; discoid Lupus erythematosus; drug induced Lupus].
    Frojo M; Lamparelli A; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Oct; 30(4):901-35. PubMed ID: 2701639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of complement testing in clinical medicine.
    Abdul-Aziz K; Faizal AA
    Saudi Med J; 2006 Nov; 27(11):1775-7. PubMed ID: 17106567
    [No Abstract]   [Full Text] [Related]  

  • 9. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
    Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
    Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus in 6 male cocaine users at Bellevue hospital.
    Rivera TL; Belmont HM; Weissmann G
    J Rheumatol; 2009 Dec; 36(12):2854-5. PubMed ID: 19966204
    [No Abstract]   [Full Text] [Related]  

  • 11. [Visceral lupus erythematosus].
    Meyer zum Büschenfelde ; Knolle J
    Med Klin; 1969 Jul; 64(29):1297-302. PubMed ID: 4184548
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility of antihistone antibody screening in the diagnosis of drug-induced lupus erythematosus.
    Zirwas MJ; Kress DW; Deng JS
    Arch Dermatol; 2004 Apr; 140(4):494-5. PubMed ID: 15096389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-induced lupus. Physiopathological data].
    Kaplan G; Bourgeois P; Kahn MF
    Therapie; 1985; 40(2):123-7. PubMed ID: 4002190
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lupus and protein deficiencies of the classical complement pathway].
    Weiss L; Maillet F; Kazatchkine M
    Rev Prat; 1990 Sep; 40(21):1937-40. PubMed ID: 2237185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D.N.A. antibodies in systemic lupus erythematosus - an evaluation and a comparison of two techniques.
    Browne O; Holland PD; Maguire P
    Ir Med J; 1981 Jul; 74(7):188-9. PubMed ID: 7021465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus].
    Xie H; Liu Z; Zhu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):177-8. PubMed ID: 9868068
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.